Shopping Cart
- Remove All
- Your shopping cart is currently empty
Grisnilimab (WT1) is a monoclonal antibody targeting CD7. CD7 plays a crucial role in T cell and T cell/B cell interactions, and the Wilms' tumour 1 (WT1) gene is overexpressed in leukaemia and various types of solid tumours (such as lung cancer and colorectal cancer).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $332 | In Stock | |
5 mg | $996 | In Stock | |
10 mg | $1,570 | In Stock | |
25 mg | $2,330 | In Stock | |
50 mg | $3,130 | In Stock |
Description | Grisnilimab (WT1) is a monoclonal antibody targeting CD7. CD7 plays a crucial role in T cell and T cell/B cell interactions, and the Wilms' tumour 1 (WT1) gene is overexpressed in leukaemia and various types of solid tumours (such as lung cancer and colorectal cancer). |
Synonyms | WT1, WT 1 |
Cas No. | 2367001-70-3 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.